Why Nurse-Delivered Telehealth Faces Real-World Hurdles

Managing comorbid diabetes and hypertension in a fee-for-service healthcare system poses massive clinical challenges. Consequently, clinicians constantly seek scalable remote solutions to support patient self-management. Specifically, a recent clinical trial investigated whether nurse-delivered telehealth can improve outcomes for high-risk patients. However, this pragmatic study revealed several surprising barriers that restricted its clinical effectiveness.

The Challenge of Fee-for-Service Care

Traditional healthcare systems often rely on fee-for-service models that do not easily support intensive remote monitoring. For instance, most clinics lack the integrated infrastructure needed to coordinate complex virtual care. Thus, implementing comprehensive digital programs remains exceptionally difficult in these settings. To address this gap, researchers designed a pragmatic, randomized trial involving six academic clinics. They enrolled patients who had both uncontrolled type 2 diabetes and comorbid hypertension. Each participant struggled with persistently high blood sugar and blood pressure. Therefore, they represented a highly vulnerable population requiring aggressive clinical management.

Implementing Nurse-Delivered Telehealth

The study compared a basic mobile self-monitoring control program against an intensive, nurse-delivered telehealth intervention. Specifically, the comprehensive program incorporated personalized self-management education and medication management over twelve months. Meanwhile, participants in the control group simply logged their own vitals using mobile devices. At the start of the study, the cohort had a mean HbA1c of 9.8 percent. Furthermore, their baseline blood pressures exceeded standard targets. Ultimately, the investigators aimed to see if active nursing support would yield significantly better glycemic control than self-monitoring alone.

Surprising Trial Results and Key Barriers

Surprisingly, the final results did not show a major statistical difference between the two treatment pathways. For example, HbA1c dropped by 1.1 percentage points in the intensive group. Meanwhile, it decreased by 0.7 percentage points in the self-monitoring control group. Consequently, the between-group difference of 0.4 percentage points did not achieve statistical significance. Why did this comprehensive program fail to deliver superior results? Crucially, the implementation analysis revealed that the clinic staff delivered the intervention with suboptimal fidelity. Specifically, the median number of patient encounters was only nine, falling short of the twelve-encounter threshold. This occurred because multiple delivery barriers, such as staff shortages and system limitations, hindered regular communication. However, the telehealth program did significantly improve patient-reported diabetes self-care scores.

Clinical Implications for Practice

For healthcare providers, these findings emphasize that technology alone cannot guarantee clinical success. Instead, successful deployment of digital solutions requires robust organizational support and streamlined workflows. If systems do not address operational barriers, even well-designed telehealth programs will likely struggle. Therefore, future initiatives must focus heavily on improving intervention fidelity and reducing administrative burdens on staff.

Frequently Asked Questions

Q1: Why did the nurse-delivered telehealth program not perform significantly better than self-monitoring?

The primary reason was suboptimal fidelity during program delivery. Specifically, participants received a median of only nine encounters, failing to reach the twelve-encounter threshold. Additionally, clinic staff shortages and fee-for-service systemic hurdles limited consistent patient contact.

Q2: Did the comprehensive telehealth intervention show any clinical benefits?

Yes, the comprehensive telehealth program significantly improved patient-reported diabetes self-care scores. Furthermore, both groups achieved notable blood sugar reductions over twelve months. However, the final between-group difference in HbA1c reduction did not reach statistical significance.

Q3: How can healthcare systems improve the success of future telehealth programs?

Healthcare systems must first address systemic operational barriers and staff shortages. Consequently, they should build robust infrastructure inside fee-for-service models to support clinicians. Ultimately, this will help teams maintain high intervention fidelity and improve patient engagement.

References

1. Crowley MJ et al. Expanding Technology-Enabled, Nurse-Delivered Chronic Disease Care : A Pragmatic, Randomized, Effectiveness-Implementation Trial. Ann Intern Med. 2026 Jun 23. doi: 10.7326/ANNALS-26-00132. PMID: 42330500.
2. German JC et al. EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND): Protocol and Baseline Data for a Randomized Trial. Contemp Clin Trials. 2024 Nov;146:107673. doi: 10.1016/j.cct.2024.107673.
3. Bashir A et al. Addressing cost and time barriers in chronic disease management through telemedicine: an exploratory research in select low- and middle-income countries. mHealth. 2024;10:12. doi: 10.21037/mhealth-23-31.